PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
8.81%
Revenue growth under 50% of AVGO's 99.94%. Michael Burry would suspect a deteriorating sales pipeline or weaker brand.
9.81%
Gross profit growth at 75-90% of AVGO's 11.16%. Bill Ackman would demand operational improvements to match competitor gains.
15.53%
Positive EBIT growth while AVGO is negative. John Neff might see a substantial edge in operational management.
15.39%
Positive operating income growth while AVGO is negative. John Neff might view this as a competitive edge in operations.
15.19%
Positive net income growth while AVGO is negative. John Neff might see a big relative performance advantage.
15.71%
Positive EPS growth while AVGO is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
14.49%
Positive diluted EPS growth while AVGO is negative. John Neff might view this as a strong relative advantage in controlling dilution.
-0.32%
Share reduction while AVGO is at 41.52%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-0.20%
Reduced diluted shares while AVGO is at 43.60%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
0.06%
Dividend growth under 50% of AVGO's 18.16%. Michael Burry might suspect more pressing needs for cash or weaker earnings power.
95.43%
OCF growth above 1.5x AVGO's 31.22%. David Dodd would confirm a clear edge in underlying cash generation.
115.37%
FCF growth above 1.5x AVGO's 38.92%. David Dodd would verify if the firm’s strategic investments yield superior returns.
37.03%
10Y revenue/share CAGR under 50% of AVGO's 494.80%. Michael Burry would suspect a lasting competitive disadvantage.
9.05%
5Y revenue/share CAGR under 50% of AVGO's 295.20%. Michael Burry would suspect a significant competitive gap or product weakness.
18.09%
3Y revenue/share CAGR under 50% of AVGO's 295.40%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
158.94%
10Y OCF/share CAGR under 50% of AVGO's 414.49%. Michael Burry would worry about a persistent underperformance in cash creation.
95.19%
5Y OCF/share CAGR above 1.5x AVGO's 54.88%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
74.36%
3Y OCF/share CAGR at 50-75% of AVGO's 104.36%. Martin Whitman would suspect weaker recent execution or product competitiveness.
-46.89%
Both face negative decade-long net income/share CAGR. Martin Whitman would suspect a shrinking or highly disrupted sector.
40.42%
Positive 5Y CAGR while AVGO is negative. John Neff might view this as a strong mid-term relative advantage.
36.42%
Positive short-term CAGR while AVGO is negative. John Neff would see a clear advantage in near-term profit trajectory.
20.58%
Below 50% of AVGO's 1318.96%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
5.27%
Below 50% of AVGO's 587.53%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
-1.05%
Negative 3Y equity/share growth while AVGO is at 373.54%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
1158.01%
Dividend/share CAGR of 1158.01% while AVGO is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
193.41%
Below 50% of AVGO's 537.50%. Michael Burry worries the firm returns far less capital to shareholders over 5 years.
35.90%
Below 50% of AVGO's 172.38%. Michael Burry suspects the firm invests elsewhere or can’t match the competitor’s dividend policy.
6.23%
AR growth is negative/stable vs. AVGO's 75.19%, indicating tighter credit discipline. David Dodd confirms it doesn't hamper actual sales.
3.93%
Inventory shrinking or stable vs. AVGO's 199.39%. David Dodd confirms the company’s supply-chain is more efficient if sales are unaffected.
0.04%
Asset growth well under 50% of AVGO's 377.01%. Michael Burry sees the competitor as far more aggressive in building resources or capacity.
2.17%
Under 50% of AVGO's 214.09%. Michael Burry raises concerns about the firm’s ability to build intrinsic value relative to its rival.
-12.29%
We’re deleveraging while AVGO stands at 281.11%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
5.90%
R&D dropping or stable vs. AVGO's 194.76%. David Dodd sees near-term margin benefits if the product pipeline is already strong.
2.95%
SG&A declining or stable vs. AVGO's 108.77%. David Dodd sees better overhead efficiency if it doesn't hamper revenue.